Clinical Trial Update: Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization. [Phase 1]

View source ↗

Summary

Phase 1 safety trial evaluating parathyroid hormone for stem cell mobilization in patients with lymphoma, multiple myeloma, or acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Lymphoma
• Multiple Myeloma

Drugs mentioned

• Parathyroid hormone (Parathyroid hormone)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Lymphoma, Multiple Myeloma | Phase 1 | Status: COMPLETED